Alirocumab reduces total coronary plaque burden in patients with familial hypercholesterolaemia and no previous clinical atherosclerotic disease

Category Primary study
Conference43rd European Society of Cardiology Congress, ESC 2022
Year 2022
This article has no abstract
Epistemonikos ID: e6097e2b35fb702e44ea20b34cb3e55704594c67
First added on: Feb 15, 2025